Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K
Embryonic Stem Cells00:57

Embryonic Stem Cells

4.7K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.7K
Embryonic Stem Cells00:58

Embryonic Stem Cells

32.0K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.0K
EPS and iPS Cells in Disease Research01:21

EPS and iPS Cells in Disease Research

3.3K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.3K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

5.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating community pharmacists' practices in managing insomnia in Saudi Arabia: a cross-sectional study using simulated patient visits.

Frontiers in public health·2026
Same author

Advancing Drug Discovery with AI: Machine and Deep Learning Strategies for Target Identification and Precision Nanomedicine.

International journal of nanomedicine·2026
Same author

Phenformin-Induced Apoptosis: A Potential Mechanism for Cervical Cancer Cell Inhibition.

International journal of molecular sciences·2026
Same author

Exploring the Lived Experience of Polypharmacy Among Patients in Jazan, Saudi Arabia: An Interpretive Description Study.

Qualitative health research·2026
Same author

Precision breast oncology: molecular insights and transformative clinical strategies.

Cancer treatment and research communications·2026
Same author

Engineering cardiac regeneration using stem cells: Cellular sources, differentiation signatures, targeted delivery, and functional recovery.

Regenerative therapy·2026

Related Experiment Video

Updated: Jan 12, 2026

Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease
06:55

Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease

Published on: November 21, 2024

1.2K

Stem cell-based interventions for epilepsy: Current progress and future promise.

Dinesh Kumar1, Mehboob's Ashraf2, Vrinda Gupta3

  • 1GNA School of Pharmacy, GNA University, Phagwara, Punjab, India.

Epileptic Disorders : International Epilepsy Journal with Videotape
|November 7, 2025
PubMed
Summary

Stem cell therapy shows promise for treating refractory epilepsy by repairing brain damage and restoring neural balance. Early trials indicate safety and potential for seizure control, offering hope for patients resistant to traditional treatments.

Keywords:
epilepsygene editinginduced pluripotent stem cellsmesenchymal stem cellsneural regenerationneural stem cellspreclinical studiesstem cell therapy

More Related Videos

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures
10:05

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures

Published on: March 18, 2021

7.5K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.4K

Related Experiment Videos

Last Updated: Jan 12, 2026

Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease
06:55

Author Spotlight: Unraveling Neural Communication and Circuit Interactions in Health and Disease

Published on: November 21, 2024

1.2K
A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures
10:05

A Model of Epileptogenesis in Rhinal Cortex-Hippocampus Organotypic Slice Cultures

Published on: March 18, 2021

7.5K
Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice
07:01

Electrophoretic Delivery of γ-aminobutyric Acid GABA into Epileptic Focus Prevents Seizures in Mice

Published on: May 16, 2019

9.4K

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Epilepsy Research

Background:

  • Epilepsy affects millions worldwide, with many patients unresponsive to current treatments.
  • Refractory epilepsy poses significant challenges due to damaged neural networks and inflammation.
  • Stem cell therapy offers a novel regenerative approach to address these underlying issues.

Purpose of the Study:

  • To review the potential of stem cell therapy for refractory epilepsy.
  • To summarize preclinical and early clinical findings.
  • To discuss future directions and challenges in the field.

Main Methods:

  • Review of preclinical studies utilizing various epilepsy models (pilocarpine, kainic acid, kindling).
  • Analysis of diverse stem cell types (embryonic, neural, iPSCs, MSCs).
  • Evaluation of early-phase clinical trial data on safety, feasibility, and efficacy.

Main Results:

  • Preclinical models show seizure reduction, cognitive enhancement, and histological repair post-transplantation.
  • Various stem cell types demonstrate unique therapeutic potential and challenges.
  • Early clinical trials suggest safety, feasibility, and positive trends in seizure control and quality of life.

Conclusions:

  • Stem cell therapy is a promising regenerative treatment for refractory epilepsy.
  • Ongoing innovations like gene editing and exosome therapy aim to overcome translational hurdles.
  • Personalized approaches, regulatory standards, and economic models are vital for clinical advancement.